Prescription Drug Labeling Promotion Act of 2012
Latest action · Feb 24, 2012 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 24, 2012
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Prescription Drug Labeling Promotion Act of 2012 - Directs the Secretary of Health and Human Services (HHS) to establish a working group to develop best practices on access to prescription drug labeling for the visually impaired.
Requires the working group to: (1) include equal representation of consumer and industry advocates; (2) promulgate guidance on best practices for pharmacies to ensure that blind and visually impaired individuals have safe, consistent, reliable, and independent access to the information in the labeling of prescription drugs; (3) consider the use of Braille, specified auditory means, and enhanced visual means to provide such access; and (4) consider whether there are technical, financial, manpower, or other factors that may fundamentally impact the ability of pharmacies with 20 or fewer retail locations to implement the best practices.
Directs the Commissioner of Food and Drugs (FDA) to conduct an informational and educational program to inform the public and pharmacists about such guidance and practices.
Directs the Comptroller General: (1) 18 months after such guidance and practices are published, to review pharmacy compliance and the extent to which access barriers continue; and (2) by September 30, 2016, to report on such review, including recommendations for reducing such barriers.
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Feb 29, 2012 to Aug 2, 2012.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-FL | Ileana Ros-Lehtinen | Feb 29, 2012 | |
| D-VA | James P. Moran | Feb 29, 2012 | |
| D-WA | Adam Smith | Mar 28, 2012 | |
| R-TN | David P. Roe | Mar 28, 2012 | |
| D-CA | Jackie Speier | Mar 28, 2012 | |
| D-OR | Suzanne Bonamici | Mar 28, 2012 | |
| D-MO | Wm. Lacy Clay | Mar 28, 2012 | |
| D-NC | David E. Price | May 8, 2012 | |
| D-MA | James P. McGovern | May 8, 2012 | |
| D-CT | Joe Courtney | Aug 2, 2012 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 24, 2012 |
Actions 2
Everything that happened, newest first.
- Feb 24, 2012Introduced in House
- Feb 24, 2012Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the page H950.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2516 | Food and Drug Administration Safety and Innovation Act | Related bill | May 7, 2012 |
| S 3187 | Food and Drug Administration Safety and Innovation Act | Related bill | Jul 9, 2012 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To provide for the development and dissemination of best practices to ensure that visually-impaired and blind individuals in the United States have safe, consistent, reliable, and independent access to the information in prescription drug labeling.
- Short Titles as Introduced
- Prescription Drug Labeling Promotion Act of 2012
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 24, 2012Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
